BSE filing, NSE: RADHIKAJWE. Summary written from the filing by ALFA Finder's alert engine.
Radhika Jeweltech Ltd: key numbers
- Share price
- ₹63.00
- Market cap
- ₹743.4 Cr
- Revenue (annual)
- ₹639.1 Cr
- Net profit (annual)
- ₹74.79 Cr
- P/E (TTM)
- 9.4×Sector 49.5×
- Promoter holding
- 57.68%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Radhika Jeweltech Ltd
All →Radhika Jeweltech Annual General Meeting
Radhika Jeweltech Ltd held its 10th Annual General Meeting on September 30, 2026. Members transacted ordinary and special business items, including re-appointing directors and adopting financial statements.
Radhika Jeweltech Annual Report
Radhika Jeweltech Ltd has filed its 10th Annual Report for the financial year 2025-26 as required under SEBI (LODR) regulations.
Radhika Jeweltech Price Movement Clarification
Radhika Jeweltech Limited clarified to the exchanges that there is no undisclosed information which could explain the recent significant increase in its share price.
Radhika Jeweltech Annual General Meeting
Radhika Jeweltech Limited has issued a notice for its 10th Annual General Meeting, scheduled to be held on September 30, 2026.
Radhika Jeweltech Q1 FY27 Results: Net Profit ₹22.9 Cr, Up 25.8% YoY
Radhika Jeweltech Ltd reported revenue from operations of ₹152.5 Cr (+53.9% YoY) and net profit of ₹22.9 Cr (+25.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹22.9 Cr · +25.8% YoY
Radhika Jeweltech Board Meeting Date
Radhika Jeweltech Ltd will hold a board meeting on August 11, 2026, to consider and approve the standalone unaudited financial results for the quarter ending June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.